Theriva’s oncolytic virus succeeds in pancreatic cancer study, but stock falls
Article Title: “Theriva’s Oncolytic Virus Succeeds in Pancreatic Cancer Study, but Stock Falls” Publication Date: May 7, 2025 As initially reported on May 7, 2025, Theriva Biologics’ experimental oncolytic virus, combined with chemotherapy, showed promising results in a Phase 2b…